The store will not work correctly when cookies are disabled.
2-Hydroxyethylamino-4,5-dihydro-1,3-benzodiazepine
ID: ALA3978568
PubChem CID: 134151905
Max Phase: Preclinical
Molecular Formula: C11H15N3O
Molecular Weight: 205.26
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: OCCNC1=NCCc2ccccc2N1
Standard InChI: InChI=1S/C11H15N3O/c15-8-7-13-11-12-6-5-9-3-1-2-4-10(9)14-11/h1-4,15H,5-8H2,(H2,12,13,14)
Standard InChI Key: BWOIZOZXUSXXSZ-UHFFFAOYSA-N
Molfile:
RDKit 2D
15 16 0 0 0 0 0 0 0 0999 V2000
6.7373 -10.9003 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.5358 -10.7156 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8873 -9.9797 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.5358 -9.2439 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7373 -9.0633 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0994 -9.5711 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0994 -10.3883 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3903 -9.1625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6813 -9.5711 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6813 -10.3883 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3903 -10.7969 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0437 -11.3575 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.8512 -11.2349 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1508 -10.4744 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9583 -10.3518 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 1 0
5 6 1 0
6 7 1 0
1 7 1 0
8 9 1 0
9 10 2 0
10 11 1 0
7 11 2 0
6 8 2 0
13 14 1 0
12 13 1 0
14 15 1 0
2 12 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 205.26 | Molecular Weight (Monoisotopic): 205.1215 | AlogP: 0.59 | #Rotatable Bonds: 2 |
Polar Surface Area: 56.65 | Molecular Species: BASE | HBA: 4 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 10.07 | CX LogP: 0.80 | CX LogD: -1.42 |
Aromatic Rings: 1 | Heavy Atoms: 15 | QED Weighted: 0.66 | Np Likeness Score: 0.11 |
References
1. McMullan M, García-Bea A, Miranda-Azpiazu P, Callado LF, Rozas I.. (2016) Substituted conformationally restricted guanidine derivatives: Probing the α2-adrenoceptors' binding pocket., 123 [PMID:27474922] [10.1016/j.ejmech.2016.07.011] |